カテゴリ： 世界, 医療/バイオ, QYResearch

抗うつ薬の世界市場2023年：モノアミンオキシダーゼ、三環系、新薬

■ 英語タイトル：Global Antidepressant Medication Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8671）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8671
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：88
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[抗うつ薬の世界市場2023年：モノアミンオキシダーゼ、三環系、新薬]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

本調査資料は抗うつ薬のグローバル市場について調査・分析し、世界の抗うつ薬市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（モノアミンオキシダーゼ、三環系、新薬）、用途別セグメント分析（病院、医学研究所、診療所、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Alkermes Plc、AbbVie Inc、Eli Lilly And Company、GlaxoSmithKline, Inc.、Merck KGAA、Pfizer Inc.、Teva Pharmaceutical Industries Ltd. (Actavis Generics)、Takeda Pharmaceutical Limited Company.、AstraZenecaなどが含まれています。抗うつ薬のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、抗うつ薬市場規模を算出する際に考慮しました。

・抗うつ薬市場の概要
- 製品の定義
- 抗うつ薬の種類別セグメント
- 世界の抗うつ薬市場規模：タイプ別分析（モノアミンオキシダーゼ、三環系、新薬）
- 抗うつ薬の用途別セグメント
- 世界の抗うつ薬市場規模：用途別分析（病院、医学研究所、診療所、その他）
- 世界の抗うつ薬市場規模予測（2018年-2029年）
- 抗うつ薬の平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- 抗うつ薬市場の競争状況およびトレンド

・抗うつ薬の地域別市場規模
- 北米の抗うつ薬市場規模（2018年-2029年）
- 米国の抗うつ薬市場規模（2018年-2029年）
- ヨーロッパの抗うつ薬市場規模（2018年-2029年）
- アジア太平洋の抗うつ薬市場規模（2018年-2029年）
- 中国の抗うつ薬市場規模（2018年-2029年）
- 日本の抗うつ薬市場規模（2018年-2029年）
- 韓国の抗うつ薬市場規模（2018年-2029年）
- インドの抗うつ薬市場規模（2018年-2029年）
- オーストラリアの抗うつ薬市場規模（2018年-2029年）
- 中南米の抗うつ薬市場規模（2018年-2029年）
- 中東・アフリカの抗うつ薬市場規模（2018年-2029年）

・種類別セグメント：モノアミンオキシダーゼ、三環系、新薬
- 世界の抗うつ薬のタイプ別販売量（2018年-2023年）
- 世界の抗うつ薬のタイプ別売上（2018年-2023年）
- 世界の抗うつ薬のタイプ別価格

・用途別セグメント：病院、医学研究所、診療所、その他
- 世界の抗うつ薬の用途別販売量（2018年-2023年）
- 世界の抗うつ薬の用途別売上（2018年-2023年）
- 世界の抗うつ薬の用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
Alkermes Plc、AbbVie Inc、Eli Lilly And Company、GlaxoSmithKline, Inc.、Merck KGAA、Pfizer Inc.、Teva Pharmaceutical Industries Ltd. (Actavis Generics)、Takeda Pharmaceutical Limited Company.、AstraZeneca

・産業チェーンと販売チャネルの分析
- 抗うつ薬産業チェーン分析
- 抗うつ薬の主要原材料
- 抗うつ薬の販売チャネル
- 抗うつ薬のディストリビューター
- 抗うつ薬の主要顧客

・抗うつ薬市場ダイナミクス
- 抗うつ薬の業界動向
- 抗うつ薬市場の成長ドライバ、課題、阻害要因

・調査の結論

・調査手法と情報源

Highlights
The global Antidepressant Medication market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Antidepressant Medication is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Antidepressant Medication is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Antidepressant Medication include Alkermes Plc, AbbVie Inc, Eli Lilly And Company, GlaxoSmithKline, Inc., Merck KGAA, Pfizer Inc., Teva Pharmaceutical Industries Ltd. (Actavis Generics), Takeda Pharmaceutical Limited Company. and AstraZeneca, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Antidepressant Medication, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antidepressant Medication.
The Antidepressant Medication market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Antidepressant Medication market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antidepressant Medication manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Alkermes Plc
AbbVie Inc
Eli Lilly And Company
GlaxoSmithKline, Inc.
Merck KGAA
Pfizer Inc.
Teva Pharmaceutical Industries Ltd. (Actavis Generics)
Takeda Pharmaceutical Limited Company.
AstraZeneca
Segment by Type
Monoamine Oxidase
Tricyclic
New Drugs
Segment by Application
Hospital
Institute of Medicine
Clinic
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Antidepressant Medication manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Antidepressant Medication in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Antidepressant Medication Market Overview
1.1 Product Overview and Scope of Antidepressant Medication
1.2 Antidepressant Medication Segment by Type
1.2.1 Global Antidepressant Medication Market Value Comparison by Type (2023-2029)
1.2.2 Monoamine Oxidase
1.2.3 Tricyclic
1.2.4 New Drugs
1.3 Antidepressant Medication Segment by Application
1.3.1 Global Antidepressant Medication Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Institute of Medicine
1.3.4 Clinic
1.3.5 Others
1.4 Global Antidepressant Medication Market Size Estimates and Forecasts
1.4.1 Global Antidepressant Medication Revenue 2018-2029
1.4.2 Global Antidepressant Medication Sales 2018-2029
1.4.3 Global Antidepressant Medication Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Antidepressant Medication Market Competition by Manufacturers
2.1 Global Antidepressant Medication Sales Market Share by Manufacturers (2018-2023)
2.2 Global Antidepressant Medication Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Antidepressant Medication Average Price by Manufacturers (2018-2023)
2.4 Global Antidepressant Medication Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Antidepressant Medication, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Antidepressant Medication, Product Type & Application
2.7 Antidepressant Medication Market Competitive Situation and Trends
2.7.1 Antidepressant Medication Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Antidepressant Medication Players Market Share by Revenue
2.7.3 Global Antidepressant Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Antidepressant Medication Retrospective Market Scenario by Region
3.1 Global Antidepressant Medication Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Antidepressant Medication Global Antidepressant Medication Sales by Region: 2018-2029
3.2.1 Global Antidepressant Medication Sales by Region: 2018-2023
3.2.2 Global Antidepressant Medication Sales by Region: 2024-2029
3.3 Global Antidepressant Medication Global Antidepressant Medication Revenue by Region: 2018-2029
3.3.1 Global Antidepressant Medication Revenue by Region: 2018-2023
3.3.2 Global Antidepressant Medication Revenue by Region: 2024-2029
3.4 North America Antidepressant Medication Market Facts & Figures by Country
3.4.1 North America Antidepressant Medication Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Antidepressant Medication Sales by Country (2018-2029)
3.4.3 North America Antidepressant Medication Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Antidepressant Medication Market Facts & Figures by Country
3.5.1 Europe Antidepressant Medication Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Antidepressant Medication Sales by Country (2018-2029)
3.5.3 Europe Antidepressant Medication Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Antidepressant Medication Market Facts & Figures by Country
3.6.1 Asia Pacific Antidepressant Medication Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Antidepressant Medication Sales by Country (2018-2029)
3.6.3 Asia Pacific Antidepressant Medication Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Antidepressant Medication Market Facts & Figures by Country
3.7.1 Latin America Antidepressant Medication Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Antidepressant Medication Sales by Country (2018-2029)
3.7.3 Latin America Antidepressant Medication Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Antidepressant Medication Market Facts & Figures by Country
3.8.1 Middle East and Africa Antidepressant Medication Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Antidepressant Medication Sales by Country (2018-2029)
3.8.3 Middle East and Africa Antidepressant Medication Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Antidepressant Medication Sales by Type (2018-2029)
4.1.1 Global Antidepressant Medication Sales by Type (2018-2023)
4.1.2 Global Antidepressant Medication Sales by Type (2024-2029)
4.1.3 Global Antidepressant Medication Sales Market Share by Type (2018-2029)
4.2 Global Antidepressant Medication Revenue by Type (2018-2029)
4.2.1 Global Antidepressant Medication Revenue by Type (2018-2023)
4.2.2 Global Antidepressant Medication Revenue by Type (2024-2029)
4.2.3 Global Antidepressant Medication Revenue Market Share by Type (2018-2029)
4.3 Global Antidepressant Medication Price by Type (2018-2029)
5 Segment by Application
5.1 Global Antidepressant Medication Sales by Application (2018-2029)
5.1.1 Global Antidepressant Medication Sales by Application (2018-2023)
5.1.2 Global Antidepressant Medication Sales by Application (2024-2029)
5.1.3 Global Antidepressant Medication Sales Market Share by Application (2018-2029)
5.2 Global Antidepressant Medication Revenue by Application (2018-2029)
5.2.1 Global Antidepressant Medication Revenue by Application (2018-2023)
5.2.2 Global Antidepressant Medication Revenue by Application (2024-2029)
5.2.3 Global Antidepressant Medication Revenue Market Share by Application (2018-2029)
5.3 Global Antidepressant Medication Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Alkermes Plc
6.1.1 Alkermes Plc Corporation Information
6.1.2 Alkermes Plc Description and Business Overview
6.1.3 Alkermes Plc Antidepressant Medication Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Alkermes Plc Antidepressant Medication Product Portfolio
6.1.5 Alkermes Plc Recent Developments/Updates
6.2 AbbVie Inc
6.2.1 AbbVie Inc Corporation Information
6.2.2 AbbVie Inc Description and Business Overview
6.2.3 AbbVie Inc Antidepressant Medication Sales, Revenue and Gross Margin (2018-2023)
6.2.4 AbbVie Inc Antidepressant Medication Product Portfolio
6.2.5 AbbVie Inc Recent Developments/Updates
6.3 Eli Lilly And Company
6.3.1 Eli Lilly And Company Corporation Information
6.3.2 Eli Lilly And Company Description and Business Overview
6.3.3 Eli Lilly And Company Antidepressant Medication Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Eli Lilly And Company Antidepressant Medication Product Portfolio
6.3.5 Eli Lilly And Company Recent Developments/Updates
6.4 GlaxoSmithKline, Inc.
6.4.1 GlaxoSmithKline, Inc. Corporation Information
6.4.2 GlaxoSmithKline, Inc. Description and Business Overview
6.4.3 GlaxoSmithKline, Inc. Antidepressant Medication Sales, Revenue and Gross Margin (2018-2023)
6.4.4 GlaxoSmithKline, Inc. Antidepressant Medication Product Portfolio
6.4.5 GlaxoSmithKline, Inc. Recent Developments/Updates
6.5 Merck KGAA
6.5.1 Merck KGAA Corporation Information
6.5.2 Merck KGAA Description and Business Overview
6.5.3 Merck KGAA Antidepressant Medication Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Merck KGAA Antidepressant Medication Product Portfolio
6.5.5 Merck KGAA Recent Developments/Updates
6.6 Pfizer Inc.
6.6.1 Pfizer Inc. Corporation Information
6.6.2 Pfizer Inc. Description and Business Overview
6.6.3 Pfizer Inc. Antidepressant Medication Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Pfizer Inc. Antidepressant Medication Product Portfolio
6.6.5 Pfizer Inc. Recent Developments/Updates
6.7 Teva Pharmaceutical Industries Ltd. (Actavis Generics)
6.6.1 Teva Pharmaceutical Industries Ltd. (Actavis Generics) Corporation Information
6.6.2 Teva Pharmaceutical Industries Ltd. (Actavis Generics) Description and Business Overview
6.6.3 Teva Pharmaceutical Industries Ltd. (Actavis Generics) Antidepressant Medication Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Teva Pharmaceutical Industries Ltd. (Actavis Generics) Antidepressant Medication Product Portfolio
6.7.5 Teva Pharmaceutical Industries Ltd. (Actavis Generics) Recent Developments/Updates
6.8 Takeda Pharmaceutical Limited Company.
6.8.1 Takeda Pharmaceutical Limited Company. Corporation Information
6.8.2 Takeda Pharmaceutical Limited Company. Description and Business Overview
6.8.3 Takeda Pharmaceutical Limited Company. Antidepressant Medication Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Takeda Pharmaceutical Limited Company. Antidepressant Medication Product Portfolio
6.8.5 Takeda Pharmaceutical Limited Company. Recent Developments/Updates
6.9 AstraZeneca
6.9.1 AstraZeneca Corporation Information
6.9.2 AstraZeneca Description and Business Overview
6.9.3 AstraZeneca Antidepressant Medication Sales, Revenue and Gross Margin (2018-2023)
6.9.4 AstraZeneca Antidepressant Medication Product Portfolio
6.9.5 AstraZeneca Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Antidepressant Medication Industry Chain Analysis
7.2 Antidepressant Medication Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Antidepressant Medication Production Mode & Process
7.4 Antidepressant Medication Sales and Marketing
7.4.1 Antidepressant Medication Sales Channels
7.4.2 Antidepressant Medication Distributors
7.5 Antidepressant Medication Customers
8 Antidepressant Medication Market Dynamics
8.1 Antidepressant Medication Industry Trends
8.2 Antidepressant Medication Market Drivers
8.3 Antidepressant Medication Market Challenges
8.4 Antidepressant Medication Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables
Table 1. Global Antidepressant Medication Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Antidepressant Medication Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Antidepressant Medication Market Competitive Situation by Manufacturers in 2022
Table 4. Global Antidepressant Medication Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Antidepressant Medication Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Antidepressant Medication Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Antidepressant Medication Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Antidepressant Medication Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Antidepressant Medication, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Antidepressant Medication, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Antidepressant Medication, Product Type & Application
Table 12. Global Key Manufacturers of Antidepressant Medication, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Antidepressant Medication by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antidepressant Medication as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Antidepressant Medication Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Antidepressant Medication Sales by Region (2018-2023) & (K Units)
Table 18. Global Antidepressant Medication Sales Market Share by Region (2018-2023)
Table 19. Global Antidepressant Medication Sales by Region (2024-2029) & (K Units)
Table 20. Global Antidepressant Medication Sales Market Share by Region (2024-2029)
Table 21. Global Antidepressant Medication Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Antidepressant Medication Revenue Market Share by Region (2018-2023)
Table 23. Global Antidepressant Medication Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Antidepressant Medication Revenue Market Share by Region (2024-2029)
Table 25. North America Antidepressant Medication Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Antidepressant Medication Sales by Country (2018-2023) & (K Units)
Table 27. North America Antidepressant Medication Sales by Country (2024-2029) & (K Units)
Table 28. North America Antidepressant Medication Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Antidepressant Medication Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Antidepressant Medication Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Antidepressant Medication Sales by Country (2018-2023) & (K Units)
Table 32. Europe Antidepressant Medication Sales by Country (2024-2029) & (K Units)
Table 33. Europe Antidepressant Medication Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Antidepressant Medication Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Antidepressant Medication Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Antidepressant Medication Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Antidepressant Medication Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Antidepressant Medication Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Antidepressant Medication Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Antidepressant Medication Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Antidepressant Medication Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Antidepressant Medication Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Antidepressant Medication Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Antidepressant Medication Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Antidepressant Medication Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Antidepressant Medication Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Antidepressant Medication Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Antidepressant Medication Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Antidepressant Medication Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Antidepressant Medication Sales (K Units) by Type (2018-2023)
Table 51. Global Antidepressant Medication Sales (K Units) by Type (2024-2029)
Table 52. Global Antidepressant Medication Sales Market Share by Type (2018-2023)
Table 53. Global Antidepressant Medication Sales Market Share by Type (2024-2029)
Table 54. Global Antidepressant Medication Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Antidepressant Medication Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Antidepressant Medication Revenue Market Share by Type (2018-2023)
Table 57. Global Antidepressant Medication Revenue Market Share by Type (2024-2029)
Table 58. Global Antidepressant Medication Price (US$/Unit) by Type (2018-2023)
Table 59. Global Antidepressant Medication Price (US$/Unit) by Type (2024-2029)
Table 60. Global Antidepressant Medication Sales (K Units) by Application (2018-2023)
Table 61. Global Antidepressant Medication Sales (K Units) by Application (2024-2029)
Table 62. Global Antidepressant Medication Sales Market Share by Application (2018-2023)
Table 63. Global Antidepressant Medication Sales Market Share by Application (2024-2029)
Table 64. Global Antidepressant Medication Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Antidepressant Medication Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Antidepressant Medication Revenue Market Share by Application (2018-2023)
Table 67. Global Antidepressant Medication Revenue Market Share by Application (2024-2029)
Table 68. Global Antidepressant Medication Price (US$/Unit) by Application (2018-2023)
Table 69. Global Antidepressant Medication Price (US$/Unit) by Application (2024-2029)
Table 70. Alkermes Plc Corporation Information
Table 71. Alkermes Plc Description and Business Overview
Table 72. Alkermes Plc Antidepressant Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Alkermes Plc Antidepressant Medication Product
Table 74. Alkermes Plc Recent Developments/Updates
Table 75. AbbVie Inc Corporation Information
Table 76. AbbVie Inc Description and Business Overview
Table 77. AbbVie Inc Antidepressant Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. AbbVie Inc Antidepressant Medication Product
Table 79. AbbVie Inc Recent Developments/Updates
Table 80. Eli Lilly And Company Corporation Information
Table 81. Eli Lilly And Company Description and Business Overview
Table 82. Eli Lilly And Company Antidepressant Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Eli Lilly And Company Antidepressant Medication Product
Table 84. Eli Lilly And Company Recent Developments/Updates
Table 85. GlaxoSmithKline, Inc. Corporation Information
Table 86. GlaxoSmithKline, Inc. Description and Business Overview
Table 87. GlaxoSmithKline, Inc. Antidepressant Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. GlaxoSmithKline, Inc. Antidepressant Medication Product
Table 89. GlaxoSmithKline, Inc. Recent Developments/Updates
Table 90. Merck KGAA Corporation Information
Table 91. Merck KGAA Description and Business Overview
Table 92. Merck KGAA Antidepressant Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Merck KGAA Antidepressant Medication Product
Table 94. Merck KGAA Recent Developments/Updates
Table 95. Pfizer Inc. Corporation Information
Table 96. Pfizer Inc. Description and Business Overview
Table 97. Pfizer Inc. Antidepressant Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Pfizer Inc. Antidepressant Medication Product
Table 99. Pfizer Inc. Recent Developments/Updates
Table 100. Teva Pharmaceutical Industries Ltd. (Actavis Generics) Corporation Information
Table 101. Teva Pharmaceutical Industries Ltd. (Actavis Generics) Description and Business Overview
Table 102. Teva Pharmaceutical Industries Ltd. (Actavis Generics) Antidepressant Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Teva Pharmaceutical Industries Ltd. (Actavis Generics) Antidepressant Medication Product
Table 104. Teva Pharmaceutical Industries Ltd. (Actavis Generics) Recent Developments/Updates
Table 105. Takeda Pharmaceutical Limited Company. Corporation Information
Table 106. Takeda Pharmaceutical Limited Company. Description and Business Overview
Table 107. Takeda Pharmaceutical Limited Company. Antidepressant Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Takeda Pharmaceutical Limited Company. Antidepressant Medication Product
Table 109. Takeda Pharmaceutical Limited Company. Recent Developments/Updates
Table 110. AstraZeneca Corporation Information
Table 111. AstraZeneca Description and Business Overview
Table 112. AstraZeneca Antidepressant Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. AstraZeneca Antidepressant Medication Product
Table 114. AstraZeneca Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Antidepressant Medication Distributors List
Table 118. Antidepressant Medication Customers List
Table 119. Antidepressant Medication Market Trends
Table 120. Antidepressant Medication Market Drivers
Table 121. Antidepressant Medication Market Challenges
Table 122. Antidepressant Medication Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Antidepressant Medication
Figure 2. Global Antidepressant Medication Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Antidepressant Medication Market Share by Type in 2022 & 2029
Figure 4. Monoamine Oxidase Product Picture
Figure 5. Tricyclic Product Picture
Figure 6. New Drugs Product Picture
Figure 7. Global Antidepressant Medication Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Antidepressant Medication Market Share by Application in 2022 & 2029
Figure 9. Hospital
Figure 10. Institute of Medicine
Figure 11. Clinic
Figure 12. Others
Figure 13. Global Antidepressant Medication Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Antidepressant Medication Market Size (2018-2029) & (US$ Million)
Figure 15. Global Antidepressant Medication Sales (2018-2029) & (K Units)
Figure 16. Global Antidepressant Medication Average Price (US$/Unit) & (2018-2029)
Figure 17. Antidepressant Medication Report Years Considered
Figure 18. Antidepressant Medication Sales Share by Manufacturers in 2022
Figure 19. Global Antidepressant Medication Revenue Share by Manufacturers in 2022
Figure 20. The Global 5 and 10 Largest Antidepressant Medication Players: Market Share by Revenue in 2022
Figure 21. Antidepressant Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 22. Global Antidepressant Medication Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 23. North America Antidepressant Medication Sales Market Share by Country (2018-2029)
Figure 24. North America Antidepressant Medication Revenue Market Share by Country (2018-2029)
Figure 25. United States Antidepressant Medication Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Canada Antidepressant Medication Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Europe Antidepressant Medication Sales Market Share by Country (2018-2029)
Figure 28. Europe Antidepressant Medication Revenue Market Share by Country (2018-2029)
Figure 29. Germany Antidepressant Medication Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. France Antidepressant Medication Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. U.K. Antidepressant Medication Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Italy Antidepressant Medication Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Russia Antidepressant Medication Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Asia Pacific Antidepressant Medication Sales Market Share by Region (2018-2029)
Figure 35. Asia Pacific Antidepressant Medication Revenue Market Share by Region (2018-2029)
Figure 36. China Antidepressant Medication Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Japan Antidepressant Medication Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. South Korea Antidepressant Medication Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. India Antidepressant Medication Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Australia Antidepressant Medication Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. China Taiwan Antidepressant Medication Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Indonesia Antidepressant Medication Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Thailand Antidepressant Medication Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Malaysia Antidepressant Medication Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Latin America Antidepressant Medication Sales Market Share by Country (2018-2029)
Figure 46. Latin America Antidepressant Medication Revenue Market Share by Country (2018-2029)
Figure 47. Mexico Antidepressant Medication Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Brazil Antidepressant Medication Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Argentina Antidepressant Medication Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Middle East & Africa Antidepressant Medication Sales Market Share by Country (2018-2029)
Figure 51. Middle East & Africa Antidepressant Medication Revenue Market Share by Country (2018-2029)
Figure 52. Turkey Antidepressant Medication Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Antidepressant Medication Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. UAE Antidepressant Medication Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Global Sales Market Share of Antidepressant Medication by Type (2018-2029)
Figure 56. Global Revenue Market Share of Antidepressant Medication by Type (2018-2029)
Figure 57. Global Antidepressant Medication Price (US$/Unit) by Type (2018-2029)
Figure 58. Global Sales Market Share of Antidepressant Medication by Application (2018-2029)
Figure 59. Global Revenue Market Share of Antidepressant Medication by Application (2018-2029)
Figure 60. Global Antidepressant Medication Price (US$/Unit) by Application (2018-2029)
Figure 61. Antidepressant Medication Value Chain
Figure 62. Antidepressant Medication Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 渓谷熱治療薬の世界市場2023年：フルコナゾール、ボリコナゾール、ポサコナゾール、アムホテリシンB、その他
  • 薬物療法管理のグローバル市場展望 2023年-2029年：インハウス、アウトハウス
  • 世界のインフルエンザ薬市場2022年：市場規模予測（～2028年）
  • ADHD治療薬の世界市場2023年：刺激薬、非刺激薬
  • 内服薬シリンジの世界市場2023年：1ml、5ml、10ml、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8671 )"抗うつ薬の世界市場2023年：モノアミンオキシダーゼ、三環系、新薬" (英文：Global Antidepressant Medication Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。